1. Home
  2. JBLU vs EVO Comparison

JBLU vs EVO Comparison

Compare JBLU & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBLU
  • EVO
  • Stock Information
  • Founded
  • JBLU 1998
  • EVO 1993
  • Country
  • JBLU United States
  • EVO Germany
  • Employees
  • JBLU N/A
  • EVO N/A
  • Industry
  • JBLU Air Freight/Delivery Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • JBLU Consumer Discretionary
  • EVO Health Care
  • Exchange
  • JBLU Nasdaq
  • EVO Nasdaq
  • Market Cap
  • JBLU 1.9B
  • EVO 1.5B
  • IPO Year
  • JBLU N/A
  • EVO 2021
  • Fundamental
  • Price
  • JBLU $4.45
  • EVO $4.08
  • Analyst Decision
  • JBLU Sell
  • EVO Buy
  • Analyst Count
  • JBLU 11
  • EVO 2
  • Target Price
  • JBLU $4.97
  • EVO $5.90
  • AVG Volume (30 Days)
  • JBLU 20.2M
  • EVO 117.0K
  • Earning Date
  • JBLU 07-29-2025
  • EVO 08-13-2025
  • Dividend Yield
  • JBLU N/A
  • EVO N/A
  • EPS Growth
  • JBLU N/A
  • EVO N/A
  • EPS
  • JBLU N/A
  • EVO N/A
  • Revenue
  • JBLU $9,210,000,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • JBLU N/A
  • EVO $10.08
  • Revenue Next Year
  • JBLU $7.75
  • EVO $10.99
  • P/E Ratio
  • JBLU N/A
  • EVO N/A
  • Revenue Growth
  • JBLU N/A
  • EVO 1.50
  • 52 Week Low
  • JBLU $3.34
  • EVO $2.84
  • 52 Week High
  • JBLU $8.31
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • JBLU 48.31
  • EVO 57.98
  • Support Level
  • JBLU $4.11
  • EVO $4.15
  • Resistance Level
  • JBLU $4.39
  • EVO $4.35
  • Average True Range (ATR)
  • JBLU 0.21
  • EVO 0.11
  • MACD
  • JBLU 0.02
  • EVO 0.03
  • Stochastic Oscillator
  • JBLU 74.70
  • EVO 98.39

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: